AI designs functional enzyme components that could help expand drug discovery

Дата публикации: 21-10-2026 20:20:14

New active ingredients for drugs to treat infections, cancer or other serious diseases are often based on substances originally discovered in microorganisms, plants or other living organisms. Producing or improving such active ingredients in a targeted manner using microorganisms is often challenging because the underlying biological processes are extremely complex.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Scientists demonstrate AI-designed enzyme for drug synthesis	0	11.37	23-10-2026
2	AI used to create synthetic virus	0	11.58	07-08-2026
3	AI lets chemists design molecules by simply describing them	0	7.35	06-05-2026
4	AI plus chemistry can expand battery electrolyte design	0	8.4	07-08-2026
5	Rewiring early drug development with AI and digitalization	0	11.88	25-06-2026
6	'24/7 unmanned synthesis platform' uses robots and light to produce drug candidates	0	6.33	19-10-2026
7	AI designs working molecular scissors that recognize and cut selected protein targets	0	7.87	16-10-2026
8	AI-powered analytics and experimental validation: Transforming target identification in drug discovery	0	8.72	23-07-2026
9	New AI platform helps uncover promising cancer drug combinations	0	9.14	22-10-2026
10	UCLA bioengineer Jason Zhang deploys AI to create proteins never before seen in nature	0	9.37	11-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.27. Источник: phys.org.